1. Introduction {#sec1-ijerph-13-00392}
===============

Diabetes mellitus (DM) is a chronic systemic metabolic disease, which not only seriously harms human health, but causes a great socioeconomic burden \[[@B1-ijerph-13-00392],[@B2-ijerph-13-00392]\]. The estimated prevalence of diabetes was 11.6% according to a national survey in China \[[@B1-ijerph-13-00392]\]. Along with the improvement of people's economic level and the change of lifestyle, the incidence of DM is expected to increase to 12.1% by 2030. Similarly, the prevalence of DM will increase in other countries by 2030, such as the U.S. (11.8%), India (9.9%) and Australia (9.3%) \[[@B3-ijerph-13-00392]\]. More and more studies indicate that the DM has become a significant global public health problem \[[@B4-ijerph-13-00392],[@B5-ijerph-13-00392]\]. Early detection, diagnosis and treatment are essential for the prevention and control of DM. Regular physical examination is an important way for early detection of DM and glucose intolerance. However DM is not noted in the general population. Many studies have found that the risk of DM would the reduced significantly if interventions or healthy lifestyles can be targeted at the abnormal group \[[@B6-ijerph-13-00392],[@B7-ijerph-13-00392]\]. Published reports show variations in the risk factors and preventive strategies for DM. Diabetes risk decreased by 10% for each percentage point of weight loss with an intensive lifestyle intervention \[[@B7-ijerph-13-00392]\]. Lin \[[@B8-ijerph-13-00392]\] and Qi \[[@B9-ijerph-13-00392]\] reported that the level of blood glucose would decrease in the high-risk population undergoing intensive lifestyle intervention. However, objective measurement is lacking on the efficacy of interventions for diabetes, and at which point a given intervention would be effective in the high-risk population should be studied. An insight into the extent of the characteristic and risk factors for abnormal blood glucose in the general population is crucial for effective intervention. The results of this study may help to assess the socioeconomic burden of DM and encourage active screening and promotion of the timely control of diabetes among the general population in China.

2. Methods {#sec2-ijerph-13-00392}
==========

2.1. Study Population {#sec2dot1-ijerph-13-00392}
---------------------

This study was performed by a cross-sectional physical examination method at Yijishan Hospital of Wannan Medical College, which is located in Wuhu City in China. The total sample, which included 175,122 cases ≥18 years old examined during 2011--2014, included 102,261 males (mean age 42.8 ± 13.0) and 72,861 females (age 40.4 ± 13.6).

2.2. Data Collection Procedure {#sec2dot2-ijerph-13-00392}
------------------------------

This study was conducted in accordance with the Declaration of Helsinki and was approved by Ethics Committee of Wannan Medical College (2010wy038). Verbal informed consent was obtained from each subject before the investigation, all participants (volunteers aged 18 years or more) were identified. All the participants were requested to complete the questionnaire, physical examination and laboratory test. Participants' demographic characteristics such as age and sex, and lifestyle habits such as smoking, and alcohol consumption were assessed by trained investigators. On the day of the survey, investigators explained the purpose of the study, the elements of informed consent, and distributed the survey. After that, participants were asked to complete questionnaires by themselves or with the help of the investigators. The completed questionnaires were checked by reviewers.

The questionnaires were followed by a general physical examination, which included a fasting blood collection, liver and kidney ultrasonography, and anthropometric assessment. The anthropometric assessments included height, weight and blood pressure. The weight was collected using a calibrated electronic digital scale, accurate to 100 g with subjects wearing only light underwear. Heights were measured to the nearest 0.1 cm using a secure portable stadiometer while wearing no shoes. The blood pressure was recorded twice by an experienced nurse in both arms with a mercury sphygmomanometer in the sitting position after a 5 min rest.

Also, blood samples were withdrawn from the antecubital vein of subjects in fasting status. High density lipoprotein (HDL), low density lipoprotein (LDL), triglyceride (TG), and total cholesterol (TC) were assessed by the clinical laboratory of the hospital. All laboratory values were assayed by an automated biochemical analysis instrument (DPP-800, Roche Pharmaceutical Ltd., Shanghai, China), using commercially available assays.

2.3. Study Definitions {#sec2dot3-ijerph-13-00392}
----------------------

In our study, glucose intolerance, DM and hypertension were considered. Diabetes mellitus was diagnosed according to the 1999 World Health Organization diagnostic criteria or previously diagnosed diabetes \[[@B10-ijerph-13-00392]\]: impaired glucose tolerance (FPG: 6.1--6.9 mmol/L); undiagnosed diabetes (FPG ≥ 7.0 mmol/L).

The diagnosis of hypertension was based on standard criteria according to the Guidelines for Prevention and Treatment of Hypertension in China \[[@B11-ijerph-13-00392]\]: Normal BP (SBP \< 120 mm Hg and diastolic BP (DBP) \< 80 mm Hg); Pre-HTN (these are patients on the cusp of developing HTN. It is defined as a SBP of 120--139 mm Hg or a DBP of 80--89 mm Hg); Stage I HTN (SBP 140--159 mm Hg or DBP 90--99 mm Hg); Stage II HTN (SBP ≥ 160 mm Hg or DBP ≥ 100 mm Hg); Stage III HTN (SBP ≥ 180 mm Hg or DBP ≥ 110 mm Hg). High TC was defined as a serum level of TC \> 6.22 mmol/L. High TG was defined as a serum level of triglyceride ≥ 2.26 mmol/L. Low HDL-C was defined as a serum level of HDL-C \< 1.04 mmol/L. Smoking or drinking was defined as smoking or drinking once a week, past behavior was considered to be no. "No" referred to no more than once a week or never, "Occasionally" referred to no more than three times a week, "Frequently" referred to more than five times a week.

2.4. Data Analysis {#sec2dot4-ijerph-13-00392}
------------------

All participant information and laboratory results were entered into a customized database, and then analyzed by the R 3.0 statistical software (Chinese Academy of Sciences, Beijing, China). Descriptive analysis and chi-square tests were conducted to analyze the general characteristics of participants regarding lifestyle habits and glucose levels. The differences between laboratory results and lifestyle habits among different glucose level groups were compared using *t*-test or Chi squared, accordingly. Multivariate logistic regression analysis was used to estimate the risk factors for hyperglycemia (hyperglycemia status as a dependent variable; gender, age, BMI, TC, HDL-C, smoking status, drinking status as independent variables). The odds ratio (OR) and its 95% confidence interval (CI) were presented to show the risks. The trend in glucose with age for the different sexes was shown with a graphic. A *p*-value \< 0.05 was considered as significant.

3. Results {#sec3-ijerph-13-00392}
==========

3.1. Prevalence of DM and IFG in Different Sexes {#sec3dot1-ijerph-13-00392}
------------------------------------------------

A total of 175,122 people were evaluated in this study, among which 72,861 were female with a mean age of 40.4 ± 13.6 years. The prevalence of frequent alcohol consumption, smoking, Normal, IFG and DM among participants were 12.9%, 24.2%, 80.8%, 6.0% and 3.8%, respectively, and males showed a significantly higher prevalence than females (*p* \< 0.001) ([Table 1](#ijerph-13-00392-t001){ref-type="table"}).

3.2. Characteristics of IFG and DM {#sec3dot2-ijerph-13-00392}
----------------------------------

As [Table 2](#ijerph-13-00392-t002){ref-type="table"} shows, participants' age, BMI, Glu, HDL, TC and TG were significantly different between different levels of plasma glucose (*p* \< 0.001). The HDL of the normal group was higher than that of the IFG and DM groups, other variables were lower. An increasing rate of IFG and DM was associated with the increasing rate of abnormal BP, smoking and alcohol consumption.

3.3. Risk Factors of Hyperglycaemia {#sec3dot3-ijerph-13-00392}
-----------------------------------

The level of blood glucose data was assigned to two groups: hyperglycemia (includes IFG and DM) and control. In a multivariate logistics analysis, using an enter method, a significant positive correlation was observed between blood glucose and participants' age, BMI, BP, TG and TC as well as inverse correlations with HDL ([Table 3](#ijerph-13-00392-t003){ref-type="table"} and [Table 4](#ijerph-13-00392-t004){ref-type="table"}). Concomitantly, smoking and alcohol use were associated with an increased risk of diabetes in males ([Table 4](#ijerph-13-00392-t004){ref-type="table"}).

3.4. The Trends of Glucose as Age {#sec3dot4-ijerph-13-00392}
---------------------------------

As [Figure 1](#ijerph-13-00392-f001){ref-type="fig"} shows, there was a strong increasing tendency of glucose level with age. The glucose of males reached a peak at the age of 65, however, it continued to increase in female. The increasing inflection point of glucose in males was younger than for females. The level of FPG was higher in males than in females before 70, but the reverse was true after 70.

4. Discussion {#sec4-ijerph-13-00392}
=============

This study was conducted among a 175,122 person physical examination population aged 18--95 from Wuhu City and the surrounding areas during 2011--2014. This large sample data only reflected the level of FPG and incidence of DM in the local population. However, a diagnosis of diabetes should not be excluded merely on the basis of glucose levels because this study included only one FPG result in this physical examination population, therefore the rate of undiagnosed diabetes was an outcome measured in our study.

Compared with the global prevalence of DM (2.8%), the local DM rate was higher (3.8%). Previous studies showed that the prevalence of DM was 2.8% in 2000, which would be expected to rise to 4.4% by 2030, and the number of DM cases would reach 5 million \[[@B3-ijerph-13-00392],[@B6-ijerph-13-00392],[@B7-ijerph-13-00392],[@B12-ijerph-13-00392]\]. However, the rate of prevalence of DM was much higher than the national result in 2010 which was 2.2%. This might be explained by the rapid socioeconomic development of different dietary habits. A study in 2011 reported a prevalence of 10.1% for DM in the city of Shanghai \[[@B13-ijerph-13-00392]\]. Another cross-sectional survey among 3919 subjects found the prevalence of DM and IFG were 5.9% and 10.0% \[[@B14-ijerph-13-00392]\]. Also, the prevalence of DM was somewhat different in different areas. This might be due to different economic levels, the age structure of the population, geographical distribution of people and dietary habits and so on.

The current study showed that the prevalence of IFG was positively correlated with age, which was similar to previous studies \[[@B15-ijerph-13-00392],[@B16-ijerph-13-00392],[@B17-ijerph-13-00392]\]. The possible reason is that oxidative phosphorylation dysfunction of islet cells, with a decrease in the amount and secretory functions, result in glucose increases with age \[[@B18-ijerph-13-00392]\]. Furthermore, this study showed a significant difference in the frequency of DM between males (5.1%) and females (2.8%). Some studies found a similar result in that the incidence of DM was higher in men than women but not others \[[@B19-ijerph-13-00392],[@B20-ijerph-13-00392],[@B21-ijerph-13-00392]\]. Habits such as smoking, alcohol consumption and physical activity levels contribute to the increase of DM in males. In addition, the results were similar to previous studies \[[@B8-ijerph-13-00392],[@B13-ijerph-13-00392],[@B22-ijerph-13-00392],[@B23-ijerph-13-00392]\], where increasing age, high BMI, high TC, high TG and low HDL increased the risk of diabetes. The process of glucose metabolism was strongly correlated with factors such as BMI, BP and TC. Also, the development and progression of DM interacts with related disease such as obesity, hypertension and hyperlipidemia. It is noteworthy that smokers and drinkers would show increased risk of diabetes compared to non-smokers and non-drinkers in males. The results can help target certain groups for DM educational initiatives, especially smokers and drinkers, so as to appropriately reduce the risk of DM in this high-risk population.

As [Figure 1](#ijerph-13-00392-f001){ref-type="fig"} shows, there was a strong increasing tendency of glucose with age. The glucose of males reached a peak at the age of 65, while it always continued increasing in females. An apparent sex and age difference in the blood glucose levels was found because of differences in physiology of sex, levels of the hormones across age and related factors \[[@B20-ijerph-13-00392],[@B24-ijerph-13-00392],[@B25-ijerph-13-00392]\]. In China, life and job stress are much greater in males than in females before retirement, so little attention has been paid to their health. Also, an unhealthy lifestyle may lead to a rise in blood glucose. In contrast, many efforts have focused on the health of males such as physical exercise, which may lead to a decrease in blood glucose concentration \[[@B26-ijerph-13-00392],[@B27-ijerph-13-00392]\]. However, the decline in circulating estrogen concentration after the menopause is associated with metabolic imbalances of glucose. Maybe these factors explain the differences among different genders before or after retirement. The result indicates that the blood glucose of males should be monitored at a younger age. Although DM is often associated with a poor prognosis, earlier detection may improve outcomes.

5. Limitations {#sec5-ijerph-13-00392}
==============

One of the major advantages of this study is that it was a large sample investigation, with subjects from the same area, which support the accuracy and stability of the result. Of course, the present study has some limitations. First, FPG but not has oral glucose tolerance test (OGTT) been used as an indicator of blood glucose because of the specificity and acceptability in physical examination groups. In general, OGTT shows higher sensitivity and specificity for diagnosis of diabetes. More studies are needed to confirm these findings in the future. Second, some questions in the questionnaire are mainly subjective and the fact the results were self-reported may lead to bias. Finally, our study failed to explore the causality relationship between blood glucose and related factors because of inherent limitations of the cross-sectional study. Despite these limitations, the results of this study are noteworthy for DM education and intervention.

6. Conclusions {#sec6-ijerph-13-00392}
==============

In summary, high prevalence of DM and IFG was observed in a large population of adults. Various factors such as age, sex and other disorders contribute to hyperglycemia, especially lifestyle habits. It is particularly important to strengthen community care of DM, screen high-risk groups and adopt appropriate preventive measures.
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###### 

Frequency of different variables related to the participants.

  Variable         Total (*n* = 175,122)   Females (*n* = 72,861)   Male (*n* = 102,261)   *t*/χ^2^   *p*
  ---------------- ----------------------- ------------------------ ---------------------- ---------- ---------
  Age              40.1 ± 13.9             40.4 ± 13.6              42.8 ± 13.0            7.8        \<0.001
  Alcohol                                                                                  49,495.9   \<0.001
   No              97,297 (63.8)           58,747 (97.7)            38,550 (41.8)                     
   Small           28,188 (18.5)           597 (1.0)                27,591 (29.9)                     
   Occasionally    7231 (4.7)              619 (1.0)                6612 (7.2)                        
   Frequently      19,740 (12.9)           167 (0.3)                19,573 (21.2)                     
  Smoking                                                                                  42,879.1   \<0.001
   No              105,542 (69.2)          59,864 (99.6)            45,678 (49.5)                     
   Small           7401 (4.9)              63 (0.1)                 7338 (7.9)                        
   Occasionally    2683 (1.8)              27 (0.0)                 2656 (2.9)                        
   Frequently      36,829 (24.2)           175 (0.3)                36,654 (39.7)                     
  Glucose **\***                                                                           922.7      \<0.001
   Normal          141,509 (80.8)          58,089 (92.1)            83,420 (87.3)                     
   IFG             10,487 (6.0)            3193 (5.1)               7294 (7.6)                        
   DM              6580 (3.8)              1779 (2.8)               4801 (5.1)                        

**\***: The glucose levels of 16,546 study participants were not collected.
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###### 

The characteristic of participants between different plasma glucose levels.

  Variable        Normal (*n* = 141,509)   IFG (*n* = 10,487)   DM (*n* = 6580)   F/χ^2^      *p*
  --------------- ------------------------ -------------------- ----------------- ----------- ---------
  Age (years)     39.52 ± 13.37            50.47 ± 12.99        53.75 ± 12.00     6552.0      \<0.001
  BMI (kg/m^2^)   23.36 ± 3.38             25.18 ± 3.30         25.66 ± 3.29      2518.2      \<0.001
  Glu (mmol/L)    5.12 ± 0.45              6.42 ± 0.24          9.26 ± 2.72       122,183.0   \<0.001
  HDL (mmol/L)    1.33 ± 0.36              1.30± 0.36           1.25 ± 0.34       172.7       \<0.001
  TC (mmol/L)     4.60 ± 0.86              4.95 ± 0.91          5.04 ± 1.03       1367        \<0.001
  TG (mmol/L)     1.47 ± 1.16              1.94 ± 1.64          2.38 ± 2.40       2016        \<0.001
  BP                                                                              7375.1      \<0.001
   Normal         58,046 (95.5)            1803 (3.0)           935 (1.5)                     
   Pre-HTN        57,948 (88.8)            4605 (7.1)           2714 (4.2)                    
   Stage I        14,327 (77.6)            2427 (13.1)          1711 (9.3)                    
   Stage II       4972 (73.7)              1002 (14.9)          769 (11.4)                    
   Stage III      919 (70.7)               225 (17.3)           156 (12.0)                    
  Alcohol                                                                         997.9       \<0.001
   No             85,911 (90.6)            5478 (5.8)           3448 (3.6)                    
   Small          24,214 (87.5)            2156 (7.8)           1301 (4.7)                    
   Occasionally   6497 (92.6)              343 (4.9)            173 (2.5)                     
   Frequently     16,172 (83.6)            1913 (9.9)           1261 (6.5)                    
  Smoking                                                                         309.0       \<0.001
   No             92,490 (89.8)            6633 (6.4)           3857 (3.7)                    
   Small          6479 (89.4)              506 (7.0)            264 (3.6)                     
   Occasionally   2408 (93.1)              117 (4.5)            61 (2.4)                      
   Frequently     31,419 (87.2)            2632 (7.3)           2000 (5.5)                    
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###### 

The factors of glucose on the logistic regression analysis in females.

  Variable        β       SE     Beta    OR     95% CI       *p*
  --------------- ------- ------ ------- ------ ------------ ---------
  Age (years)     0.06    0.00   4.72    1.07   1.06--1.07   \<0.001
  BMI (kg/m^2^)   0.08    0.01   1.44    1.08   1.07--1.10   \<0.001
  TG (mmol/L)     0.18    0.02   0.93    1.19   1.15--1.24   \<0.001
  TC (mmol/L)     0.16    0.03   0.84    1.17   1.1--1.25    \<0.001
  HDL (mmol/L)    −0.61   0.09   −1.28   0.54   0.45--0.65   \<0.001
  BP                                                         
   Normal         0       \-             1      \-           
   Pre-HTN        0.50    0.07           1.65   1.43--1.91   \<0.001
   Stage I        0.80    0.09           2.23   1.89--2.64   \<0.001
   Stage II       0.92    0.11           2.51   2.01--3.13   \<0.001
   Stage III      1.15    0.23           3.17   2.02--4.97   \<0.001
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###### 

The factors of glucose on the logistic regression analysis in males.

  Variable              β       SE     Beta    OR     95% CI       *p*
  --------------------- ------- ------ ------- ------ ------------ ---------
  Age (years)           0.06    0.00   3.16    1.06   1.06--1.06   \<0.001
  BMI (kg/m^2^)         0.09    0.01   1.22    1.09   1.08--1.10   \<0.001
  TG (mmol/L)           0.13    0.01   0.85    1.14   1.12--1.16   \<0.001
  TC (mmol/L)           0.23    0.02   0.86    1.26   1.21--1.31   \<0.001
  HDL (mmol/L)          −0.50   0.06   -0.67   0.61   0.54--0.69   \<0.001
  BP                                                               
   Normal               0       \-             1      \-           
   Pre-HTN              0.29    0.05           1.33   1.21--1.47   \<0.001
   Stage I              0.56    0.06           1.76   1.58--1.96   \<0.001
   Stage II             0.71    0.07           2.03   1.79--2.31   \<0.001
   Stage III            0.65    0.11           1.92   1.55--2.40   \<0.001
  Smoking                                                          
   No                   0       \-             1      \-           
   Small/Occasionally   −0.11   0.07           0.89   0.78--1.02   0.085
   Frequently           0.14    0.04           1.15   1.07--1.24   \<0.001
  Alcohol                                                          
   No                   0       \-             1      \-           
   Small/Occasionally   −0.01   0.04           0.99   0.91--1.07   0.725
   Frequently           0.16    0.04           1.17   1.07--1.28   0.001
